Smith & Nephew PLC
Chiusa
1,040 3.28
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
1007
Massimo
1014.5
Entrata | -42M 301M |
|---|---|
Vendite | -234M 3.1B |
P/E Media del settore | 19.824 32.138 |
Rendimento da dividendi | 3.73 |
Margine di Profitto | 9.784 |
Dipendenti | 17,000 |
EBITDA | -113M 773M |
Rendimento da dividendi Media del settore | 3.73% 3.59% |
|---|---|
Prossima data del Dividendo | 6 nov 2026 |
Prossima data del' Ex Dividendo | 1 ott 2026 |
Capitalizzazione di Mercato | -390M 9B |
|---|---|
Apertura precedente | 1036.72 |
Chiusura precedente | 1040 |
Smith & Nephew PLC Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Notizie correlate
Confronto tra pari
Modifica del prezzo
Smith & Nephew PLC Previsione
Notizie finanziarie
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$
Chi Siamo Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
